Current Therapeutics, Their Problems and Thiol Metabolism as Potential Drug Targets in Leishmaniasis

E-ISSN： 1875-5453|17|9|897-919

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.17, Iss.9, 2016-11, pp. : 897-919

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malaria and Leishmaniasis: Current Status of Chemotherapy, New Leads and Targets for Drug Discovery

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 8, Iss. 3, 2009-07 ,pp. : 226-267

Bentham Science Publishers

Access to resources Recommend Favorite

Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 1, 2017-12 ,pp. : 26-41

Bentham Science Publishers

Access to resources Recommend Favorite

Glycerolipid Acyltransferases in Triglyceride Metabolism and Energy Homeostasis-Potential as Drug Targets

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 12, Iss. 2, 2012-01 ,pp. : 197-206

Bentham Science Publishers

Access to resources Recommend Favorite

Thiol Proteases: Inhibitors and Potential Therapeutic Targets

Current Medicinal Chemistry, Vol. 13, Iss. 5, 2006-03 ,pp. : 547-581

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Targets in Mycobacterial Sulfur Metabolism

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 140-158

Bentham Science Publishers

Access to resources Recommend Favorite